Besides, quantitative PCR and immunoblot analysis were also used to test whether DHT stimulation also inhibits ARHGEF2 expression in AR-negative prostate cancer cell lines (PC3 and DU145) (Fig. 2D, E and Supplementary Fig. 3D, E). This evidence concerns the gene ARHGEF2 and prostate carcinoma.